SEC filing · 8-K

BioAtla, Inc.: Executive or director change

BioAtla announced the resignation of its Chief Medical Officer and updated retention and performance bonus plans for its CEO and CFO.

Filed September 29, 2026

Mixed for the company

What happened

Chief Medical Officer Dr. Eric Sievers resigned on September 25, 2026, and entered into a consulting agreement through June 30, 2027.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to BioAtla, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.